Exploring the decline in Biocon's stock value, challenges faced by the company, and an overview of its business and acquisitions.
A couple of days ago, Biocon announced that it had finally finished integrating Viatris’ business with itself. And since this was probably Biocon’s biggest acquisition till date, in today’s episode for 9th September 2023, we thought it’d be a good time to see what this biopharmaceutical company has been up to.
Watch our latest YouTube - https://www.youtube.com/watch?v=FO_NA4DKLVQ